ESR1 and breast carcinoma: In a study of 65 patients, researchers found that nearly two thirds of samples lacked ER expression; a subsequent study of 45 patients revealed that ER was positive in 60% of specimens.30,31 Using IHC in determining breast cancer receptor status is resource-intensive and requires expensive reagents, equipment, and trained personnel.